Literature DB >> 24369918

Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.

Elayne Hondares1, José M Gallego-Escuredo1, Pavel Flachs2, Andrea Frontini3, Ruben Cereijo1, Alberto Goday4, Jessica Perugini3, Pavel Kopecky5, Marta Giralt1, Saverio Cinti3, Jan Kopecky2, Francesc Villarroya6.   

Abstract

OBJECTIVE: In rodents, brown (BAT) and white (WAT) adipose tissues are targets and expression sites for fibroblast growth factor-21 (FGF21). In contrast, human WAT expresses negligible levels of FGF21. We examined FGF21 expression in human BAT samples, including the induced BAT found in adult patients with pheochromocytoma, and interscapular and visceral BAT from newborns.
METHODS: The expression of FGF21 and uncoupling protein-1 (UCP1, a brown adipocyte marker), was determined by quantitative real-time-PCR and immunoblotting. The transcript levels of marker genes for developmentally-programmed BAT (zinc-finger-protein of the cerebellum-1, ZIC1) and inducible-BAT (cluster of differentiation-137, CD137) were also determined.
RESULTS: FGF21 and UCP1 are significantly expressed in visceral adipose tissue from pheochromocytoma patients, but not in visceral fat from healthy individuals. In neonates, FGF21 and UCP1 are both expressed in visceral and interscapular fat, and their expression levels show a significant positive correlation. Marker gene expression profiles suggest that inducible BAT is present in visceral fat from pheochromocytoma patients and neonates, whereas developmentally-programmed BAT is present in neonatal interscapular fat.
CONCLUSIONS: Human BAT, but not WAT, expresses FGF21. The expression of FGF21 is especially high in inducible, also called beige/brite, neonatal BAT, but it is also found in the interscapular, developmentally-programmed, BAT of neonates.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beige adipocyte; Brite adipocyte; Diabetes; Obesity

Mesh:

Substances:

Year:  2013        PMID: 24369918     DOI: 10.1016/j.metabol.2013.11.014

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  30 in total

Review 1.  Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Authors:  Chiara Degirolamo; Carlo Sabbà; Antonio Moschetta
Journal:  Nat Rev Drug Discov       Date:  2015-11-16       Impact factor: 84.694

Review 2.  Non-sympathetic control of brown adipose tissue.

Authors:  R Cereijo; J Villarroya; F Villarroya
Journal:  Int J Obes Suppl       Date:  2015-08-04

Review 3.  Immune regulation of metabolic homeostasis in health and disease.

Authors:  Jonathan R Brestoff; David Artis
Journal:  Cell       Date:  2015-03-26       Impact factor: 41.582

4.  New research developments and insights from Metabolism.

Authors:  Olivia M Farr; Michelle Camp; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-12-17       Impact factor: 8.694

Review 5.  Developmental influences on circuits programming susceptibility to obesity.

Authors:  Lori M Zeltser
Journal:  Front Neuroendocrinol       Date:  2015-07-21       Impact factor: 8.606

6.  Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.

Authors:  J M Gallego-Escuredo; J Gómez-Ambrosi; V Catalan; P Domingo; M Giralt; G Frühbeck; F Villarroya
Journal:  Int J Obes (Lond)       Date:  2014-05-12       Impact factor: 5.095

7.  Adipocyte Browning and Higher Mitochondrial Function in Periadrenal But Not SC Fat in Pheochromocytoma.

Authors:  Laurent Vergnes; Graeme R Davies; Jason Y Lin; Michael W Yeh; Masha J Livhits; Avital Harari; Michael E Symonds; Harold S Sacks; Karen Reue
Journal:  J Clin Endocrinol Metab       Date:  2016-08-30       Impact factor: 5.958

Review 8.  Adipose tissue in control of metabolism.

Authors:  Liping Luo; Meilian Liu
Journal:  J Endocrinol       Date:  2016-12       Impact factor: 4.286

9.  Effects of central FGF21 infusion on the hypothalamus-pituitary-thyroid axis and energy metabolism in rats.

Authors:  Umit Yilmaz; Suat Tekin; Mehmet Demir; Yilmaz Cigremis; Suleyman Sandal
Journal:  J Physiol Sci       Date:  2018-02-07       Impact factor: 2.781

10.  BACE-1, PS-1 and sAPPβ Levels Are Increased in Plasma from Sporadic Inclusion Body Myositis Patients: Surrogate Biomarkers among Inflammatory Myopathies.

Authors:  Marc Catalán-García; Glòria Garrabou; Constanza Morén; Mariona Guitart-Mampel; Ingrid Gonzalez-Casacuberta; Adriana Hernando; Jose Miquel Gallego-Escuredo; Dèlia Yubero; Francesc Villarroya; Raquel Montero; Albert Selva O-Callaghan; Francesc Cardellach; Josep Maria Grau
Journal:  Mol Med       Date:  2015-11-03       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.